Authors
Heerspink, Hiddo J LStack, Austin G
Terkeltaub, Robert
Greene, Tom A
Inker, Lesley A
Bjursell, Magnus
Perl, Shira
Rikte, Tord
Erlandsson, Fredrik
Perkovic, Vlado
Issue Date
2022-08Keywords
URAT1 inhibitorChronic kidney disease
hyperuricaemia
randomized controlled clinical trial
verinurad
Metadata
Show full item recordJournal
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal AssociationDOI
10.1093/ndt/gfab237PubMed ID
34383954Item Type
ArticleOther
Language
enEISSN
1460-2385ae974a485f413a2113503eed53cd6c53
10.1093/ndt/gfab237
Scopus Count
Collections
The following license files are associated with this item:
- Creative Commons
Except where otherwise noted, this item's license is described as © The Author(s) 2021. Published by Oxford University Press on behalf of ERA-EDTA.
Related articles
- Effect of Intensive Urate Lowering With Combined Verinurad and Febuxostat on Albuminuria in Patients With Type 2 Diabetes: A Randomized Trial.
- Authors: Stack AG, Dronamraju N, Parkinson J, Johansson S, Johnsson E, Erlandsson F, Terkeltaub R
- Issue date: 2021 Apr
- Verinurad Plus Allopurinol for Heart Failure With Preserved Ejection Fraction: The AMETHYST Randomized Clinical Trial.
- Authors: Kitzman DW, Voors AA, Mentz RJ, Lewis GD, Perl S, Myte R, Kaguthi G, Sjöström CD, Källgren C, Shah SJ
- Issue date: 2024 Oct 1
- Dapagliflozin Added to Verinurad Plus Febuxostat Further Reduces Serum Uric Acid in Hyperuricemia: The QUARTZ Study.
- Authors: Stack AG, Han D, Goldwater R, Johansson S, Dronamraju N, Oscarsson J, Johnsson E, Parkinson J, Erlandsson F
- Issue date: 2021 Apr 23
- A semi-mechanistic exposure-response model to assess the effects of verinurad, a potent URAT1 inhibitor, on serum and urine uric acid in patients with hyperuricemia-associated diseases.
- Authors: Leander J, Sunnåker M, Rekić D, Aksenov S, Eriksson UG, Johansson S, Parkinson J
- Issue date: 2021 Aug
- Verinurad combined with febuxostat in Japanese adults with gout or asymptomatic hyperuricaemia: a phase 2a, open-label study.
- Authors: Shiramoto M, Liu S, Shen Z, Yan X, Yamamoto A, Gillen M, Ito Y, Hall J
- Issue date: 2018 Sep 1